Literature DB >> 9627943

Systemic immunization with urease protects mice against Helicobacter pylori infection.

B Guy1, C Hessler, S Fourage, J Haensler, E Vialon-Lafay, B Rokbi, M J Millet.   

Abstract

The ability of systemic immunization to induce protection against Helicobacter pylori infection has been evaluated in a mouse model. It was observed that if appropriate formulations and adjuvants were used such immunization elicited in outbred Swiss mice levels of protection similar or better than those induced by the oral route in the presence of cholera toxin or Escherichia coli heat labile toxin. Recombinant urease mixed with adjuvants, which induced strong Th1 and Th2 responses elicited better protection than urease mixed with adjuvants which induced a predominant Th2 type response only. These experiments demonstrate the feasibility of parenteral immunization against H. pylori and suggest that an appropriate balance between Th1 and Th2 type responses is required to achieve complete protection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9627943     DOI: 10.1016/s0264-410x(97)00258-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  37 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 2.  Evaluation of events occurring at mucosal surfaces: techniques used to collect and analyze mucosal secretions and cells.

Authors:  Bruno Guy
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

3.  Assessment of Helicobacter pylori gene expression within mouse and human gastric mucosae by real-time reverse transcriptase PCR.

Authors:  B Rokbi; D Seguin; B Guy; V Mazarin; E Vidor; F Mion; M Cadoz; M J Quentin-Millet
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Effect of low-dose antigen exposure on development of immunity to Helicobacter pylori infection in mice.

Authors:  F J Radcliff; R L Ferrero
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  Systemic immune responses to oral administration of recombinant attenuated Salmonella typhimurium expressing Helicobacter pylori urease in mice.

Authors:  Xiao-Feng Liu; Jia-Lu Hu; Qi-Zheng Quan; Zi-Qin Sun; Yao-Jun Wang; Feng Qi
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

6.  Effects of the nature of adjuvant and site of parenteral immunization on the serum and mucosal immune responses induced by a nasal boost with a vaccine alone.

Authors:  B Guy; S Fourage; C Hessler; V Sanchez; M J Millet
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

7.  Cure of Helicobacter pylori infection and resolution of gastritis by adoptive transfer of splenocytes in mice.

Authors:  K A Eaton; M E Mefford
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

8.  Immunological response to parenteral vaccination with recombinant hepatitis B virus surface antigen virus-like particles expressing Helicobacter pylori KatA epitopes in a murine H. pylori challenge model.

Authors:  Michael Kotiw; Megan Johnson; Manisha Pandey; Scott Fry; Stuart L Hazell; Hans J Netter; Michael F Good; Colleen Olive
Journal:  Clin Vaccine Immunol       Date:  2011-12-28

9.  The rOmp22-HpaA fusion protein confers protective immunity against helicobacter pylori in mice.

Authors:  Xueyong Huang; Bianli Xu; Guangcai Duan; Chunhua Song
Journal:  Curr Microbiol       Date:  2013-05-30       Impact factor: 2.188

10.  CTLA-4 blockade inhibits induction of Helicobacter pylori-associated gastritis in mice.

Authors:  K Watanabe; K Murakami; R Sato; T Okimoto; K Maeda; M Nasu; A Nishizono; T Fujioka
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.